![Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a](https://www.thelancet.com/cms/attachment/b611936d-5800-49ea-ab56-e932ddaa3aa7/gr1_lrg.jpg)
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a
![Somministrazione della seconda dose di richiamo (second booster) | emergenzacoronavirus.regione.umbria.it Somministrazione della seconda dose di richiamo (second booster) | emergenzacoronavirus.regione.umbria.it](https://emergenzacoronavirus.regione.umbria.it/sites/default/files/2022-04/14_aprile_seconda_dose3.png)
Somministrazione della seconda dose di richiamo (second booster) | emergenzacoronavirus.regione.umbria.it
![Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modelling study - The Lancet Regional Health – Europe Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modelling study - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/attachment/8e12c621-3ea3-4382-ab8a-bed2220e31e6/gr1.jpg)